Emphasys Medical Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

Emphasys Medical General Information

Description

Developer of minimally invasive therapies designed to treat chronic obstructive pulmonary diseases (COPD). The company's therapies are focused on treating emphysema, which is characterized by the gradual, irreversible breakdown of lung tissue and loss of elasticity within the lungs, enabling doctors to treat COPD easily.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 700 Chesapeake Drive
  • Redwood City, CA 94063
  • United States
+1 (650)
Primary Industry
Other Devices and Supplies
Acquirer
Corporate Office
  • 700 Chesapeake Drive
  • Redwood City, CA 94063
  • United States
+1 (650)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Emphasys Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 13-May-2009 Completed Generating Revenue
7. IPO 12-May-2008 Cancelled Generating Revenue
6. Later Stage VC (Series E) 01-Jun-2006 Completed Generating Revenue
5. Later Stage VC (Series D) 01-Jun-2004 Completed Startup
4. Later Stage VC (Series C) 01-Feb-2003 Completed Startup
3. Accelerator/Incubator Completed Generating Revenue
2. Early Stage VC (Series B) 01-Mar-2002 $9.4M $13.4M Completed Startup
1. Early Stage VC (Series A) 01-Mar-2001 $3.98M $3.98M Completed Startup
To view Emphasys Medical’s complete valuation and funding history, request access »

Emphasys Medical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series E
Series D
Series C
Series B 6,295,902 $0.001000 $0.12 $1.5 $1.5 1x $1.5 13.03%
Series A 3,985,000 $0.001000 $0.08 $1 $1 1x $1 8.18%
To view Emphasys Medical’s complete cap table history, request access »

Emphasys Medical Patents

Emphasys Medical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2008027293-A2 Bronchial isolation devices for placement in short lumens Inactive 25-Aug-2006
WO-2008027293-A3 Bronchial isolation devices for placement in short lumens Inactive 25-Aug-2006
WO-2008027293-A8 Bronchial isolation devices for placement in short lumens Inactive 25-Aug-2006
WO-2007100846-A2 Endoscopic tool Inactive 28-Feb-2006
WO-2007100846-A3 Endoscopic tool Inactive 28-Feb-2006 A61B1/05
To view Emphasys Medical’s complete patent history, request access »

Emphasys Medical Former Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
ABS Ventures Venture Capital Minority
Advanced Technology Ventures Venture Capital Minority
Hoffman Estates Corporation Minority
Morgan Stanley Expansion Capital Growth/Expansion Minority
Morgenthaler Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

Emphasys Medical FAQs

  • When was Emphasys Medical founded?

    Emphasys Medical was founded in 2000.

  • Where is Emphasys Medical headquartered?

    Emphasys Medical is headquartered in Redwood City, CA.

  • What industry is Emphasys Medical in?

    Emphasys Medical’s primary industry is Other Devices and Supplies.

  • Is Emphasys Medical a private or public company?

    Emphasys Medical is a Private company.

  • What is Emphasys Medical’s current revenue?

    The current revenue for Emphasys Medical is .

  • How much funding has Emphasys Medical raised over time?

    Emphasys Medical has raised $74.1M.

  • Who are Emphasys Medical’s investors?

    ABS Ventures, Advanced Technology Ventures, Hoffman Estates, Morgan Stanley Expansion Capital, and Morgenthaler are 5 of 10 investors who have invested in Emphasys Medical.

  • When was Emphasys Medical acquired?

    Emphasys Medical was acquired on 13-May-2009.

  • Who acquired Emphasys Medical?

    Emphasys Medical was acquired by Pulmonx.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process